Detalhe da pesquisa
1.
FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells.
BMC Biol
; 19(1): 173, 2021 08 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34433435
2.
The sVEGFR1-i13 splice variant regulates a ß1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.
Br J Cancer
; 118(12): 1596-1608, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29795310
3.
"Polymultivalent" Polymer-Peptide Cluster Conjugates for an Enhanced Targeting of Cells Expressing αvß3 Integrins.
Bioconjug Chem
; 28(9): 2241-2245, 2017 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-28767233
4.
Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting.
Nanomaterials (Basel)
; 11(1)2021 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33445812
5.
Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
Head Neck
; 41(2): 403-410, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30548507
6.
The presence of PEG on nanoparticles presenting the c[RGDfK]- and/or ATWLPPR peptides deeply affects the RTKs-AKT-GSK3ß-eNOS signaling pathway and endothelial cells survival.
Int J Pharm
; 568: 118507, 2019 Sep 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31299336